| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | UFI | Common Stock | Award | $0 | +14.6K | +0.63% | $0.00 | 2.34M | 29 Oct 2024 | Direct | F1 |
| holding | UFI | Common Stock | 30K | 29 Oct 2024 | By wife | F2 | |||||
| holding | UFI | Common Stock | 130K | 29 Oct 2024 | By Invemed Associates LLC | F3 |
| Id | Content |
|---|---|
| F1 | Represents a grant of unrestricted units of common stock from the issuer for services as a director of the issuer. The units were fully vested on the date of grant and will be converted into an equivalent number of shares of the issuer's common stock following the reporting person's termination of services as a director of the issuer. |
| F2 | The reporting person disclaims beneficial ownership of these securities, and this Form 4 shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose. |
| F3 | The reporting person is the principal equity holder and Chairman and CEO of Invemed Associates LLC. Pursuant to Instruction (4)(b)(iv) of Form 4, the reporting person has elected to report as indirectly beneficially owned the entire number of securities beneficially owned by such entity. The reporting person disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his pecuniary interest therein and/or are not actually distributed to him. |
Exhibit List: Exhibit 24 - Power of Attorney